SCHEMBL6997182

SCHEMBL6997182

O=C(CCCOc1cccc(-c2n[nH]c3c2Cc2ccccc2-3)c1)NCCN1CCOCC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 16/20 0.51
MARK3 P27448 3/20 0.50
MARK2 Q7KZI7 3/20 0.50
AURKB Q96GD4 3/20 0.50
KDR P35968 3/20 0.50
RET P07949 2/20 0.50
RPS6KA3 P51812 2/20 0.50
MELK Q14680 2/20 0.50
BRSK1 Q8TDC3 2/20 0.50
PDGFRA P16234 1/20 0.50
CDK2 P24941 1/20 0.50
FLT4 P35916 1/20 0.50
TYRO3 Q06418 1/20 0.50
CAMK2G Q13555 1/20 0.50
CAMK2D Q13557 1/20 0.50
MAP4K5 Q9Y4K4 1/20 0.50
FLT3 P36888 2/20 0.49
MAP4K4 O95819 1/20 0.49
PHKG2 P15735 1/20 0.49
RPS6KB1 P23443 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6993956 0.93 HSD17B10 (0.56) CHEK1MARK3MARK2AURKBKDR
SCHEMBL7703429 0.88 CHEK1 (0.63) CHEK1MARK3MARK2AURKBKDR
SCHEMBL7699601 0.87 CHEK1 (0.62) CHEK1MARK3MARK2AURKBKDR
SCHEMBL7701562 0.82 KDR (0.44) CHEK1MARK3MARK2AURKBKDR
SCHEMBL7700924 0.80 KDR (0.67) CHEK1MARK3MARK2AURKBKDR
SCHEMBL7090918 0.80 KDR (0.58) CHEK1KDRCDK2
SCHEMBL6995193 0.80 KDR (0.55) CHEK1MARK3MARK2AURKBKDR
SCHEMBL7703663 0.79 CHEK1 (0.62) CHEK1MARK3MARK2AURKBKDR
SCHEMBL7147004 0.79 KDR (0.68) CHEK1MARK3MARK2AURKBKDR
SCHEMBL7094673 0.79 CD274 (0.59) CHEK1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP claimed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO claimed
EP-1289525-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS Abbott GmbH & Co. KG (DE) 2003-03-12 EP disclosed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
WO-2001087846-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS ABBOTT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG & COMPANY KOMMANDITGESELLSCHAFT (DE) 2001-11-22 WO disclosed